June 5-7, 2017
The FDA and ISPE have expressed a willingness to leverage their combined strengths for the joint development of the substantive actions of this annual conference to provide a forum to discuss manufacturing, quality and management practices that create, implement and sustain a culture of quality and result in reliable pharmaceutical products that support patient health.
Goals and Objectives
FDA co-sponsorship of the conference(s) will ensure widespread opportunity for global regulatory agencies and industry leaders to engage in information dissemination and issue prioritization.
Who Should Attend
This annual conference is intended for engineers, regulators, and scientists working in the areas of pharmaceutical quality, product development, compliance, manufacturing, and regulatory affairs. The topics for the conference are selected to meet the professional and scientific concerns that typify the work of global regulators and industry leaders in drug development, manufacturing, and quality. The session content will be developed so that individuals with varying years of experience can benefit from and contribute to the conference.
The primary audience includes academic, industrial, and regulatory experts, but may also include pharmaceutical companies, regulatory agencies, non-profit organizations, and other healthcare sectors, drawing scientists and clinicians involved in drug development and regulatory decision in the US and abroad.